Health Condition 1: K089- Disorder of teeth and supporting structures, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Systemically healthy patient Patient age ranging 18-35 years Papillary and papillary penetrating frenal attachment Patient who have agreed to participate in the study
Exclusion criteria
Exclusion criteria: The patients who are undergoing treatment with analgesics or corticosteroids during the trial period Pregnancy and lactating mothers Smokers and alcoholic Patients with cardiovascular disease and stroke Patients with gastrointestinal bleeding or ulcers Patients with liver disease Patients with kidney disease Patients with known hypersensitivity reactions to oral enzyme combinations and diclofenac
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the analgesic, anti-inflammatory and wound healing efficacy of oral enzyme combination with diclofenac sodium versus diclofenac sodium alone following frenectomyTimepoint: 1 day, 3 days, 7 days | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare and evaluate the efficacy of analgesic, anti-inflammatory and wound healing efficacy of oral enzyme combination with diclofenac sodium and diclofenac sodium alone following frenectomyTimepoint: 1 day, 3 days, 7 days | — |
Countries
India
Contacts
KVG Dental College and Hospital